22.8 USD
-0.25 (-1.08%)
Taking everything into account, LFMDP scores 3 out of 10 in our fundamental rating. LFMDP was compared to 35 industry peers in the Health Care Technology industry. LFMDP may be in some trouble as it scores bad on both profitability and health. LFMDP is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
LFMDP had negative earnings in the past year.
In the past year LFMDP had a positive cash flow from operations.
LFMDP had negative earnings in each of the past 5 years.
In multiple years LFMDP reported negative operating cash flow during the last 5 years.
1.2 Ratios
LFMDP has a Return On Assets (-12.28%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 87.57%, LFMDP belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
In the last couple of years the Gross Margin of LFMDP has grown nicely.
The Profit Margin and Operating Margin are not available for LFMDP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMDP has more shares outstanding
LFMDP has more shares outstanding than it did 5 years ago.
LFMDP has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.31 indicates that LFMDP is not in any danger for bankruptcy at the moment.
LFMDP's Altman-Z score of 7.31 is amongst the best of the industry. LFMDP outperforms 85.71% of its industry peers.
LFMDP has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMDP would need 2.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.31, LFMDP is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 7.31 |
ROIC/WACCN/A
WACC9.89%
2.3 Liquidity
A Current Ratio of 0.77 indicates that LFMDP may have some problems paying its short term obligations.
LFMDP's Current ratio of 0.77 is on the low side compared to the rest of the industry. LFMDP is outperformed by 82.86% of its industry peers.
A Quick Ratio of 0.72 indicates that LFMDP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.72, LFMDP is doing worse than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
LFMDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.13%, which is quite impressive.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.27%.
Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
Based on estimates for the next years, LFMDP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.36% on average per year.
Based on estimates for the next years, LFMDP will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5Y18.36%
Revenue Next Year23.06%
Revenue Next 2Y20.09%
Revenue Next 3Y19.18%
Revenue Next 5Y3.16%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 95.80, which means the current valuation is very expensive for LFMDP.
LFMDP's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.22. LFMDP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 95.8 |
4.2 Price Multiples
LFMDP's Enterprise Value to EBITDA is on the same level as the industry average.
LFMDP's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 163.82 | ||
| EV/EBITDA | 127.32 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LFMDP's earnings are expected to grow with 40.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.23%
EPS Next 3Y40.83%
5. Dividend
5.1 Amount
LFMDP has a Yearly Dividend Yield of 9.44%, which is a nice return.
LFMDP's Dividend Yield is rather good when compared to the industry average which is at 4.61. LFMDP pays more dividend than 100.00% of the companies in the same industry.
LFMDP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.44% |
5.2 History
LFMDP has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-34.38%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
NASDAQ:LFMDP (12/3/2025, 3:52:28 PM)
22.8
-0.25 (-1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners53.98%
Inst Owner ChangeN/A
Ins Owners18.82%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)212.45M
Net Income(TTM)-9.03M
Analysts81.43
Price Target67.79 (197.32%)
Short Float %0%
Short Ratio0.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.44% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)38.6%
PT rev (3m)141.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-89.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 95.8 | ||
| P/S | 4.47 | ||
| P/FCF | 163.82 | ||
| P/OCF | 56.35 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 127.32 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.24
Fwd EY1.04%
FCF(TTM)0.14
FCFY0.61%
OCF(TTM)0.4
OCFY1.77%
SpS5.1
BVpS-0.04
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 7.31 |
F-Score5
WACC9.89%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5Y18.36%
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year23.06%
Revenue Next 2Y20.09%
Revenue Next 3Y19.18%
Revenue Next 5Y3.16%
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.54%
EBIT Next 3Y69.78%
EBIT Next 5Y43.22%
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC - LFMD 8 7/8 PERP / LFMDP FAQ
What is the ChartMill fundamental rating of LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFMDP.
What is the valuation status of LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFEMD INC - LFMD 8 7/8 PERP (LFMDP). This can be considered as Overvalued.
What is the profitability of LFMDP stock?
LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) has a profitability rating of 2 / 10.
Can you provide the dividend sustainability for LFMDP stock?
The dividend rating of LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) is 4 / 10 and the dividend payout ratio is -34.38%.